135 related articles for article (PubMed ID: 2932669)
1. Components of the alternative pathway of complement in otitis media with effusion.
Parker MJ; Leopold DA; Stitzel AE; Welch TR; Weiner LB; Spitzer RE
Otolaryngol Head Neck Surg; 1985 Oct; 93(5):607-11. PubMed ID: 2932669
[TBL] [Abstract][Full Text] [Related]
2. [Alternative complement pathway (author's transl)].
Kazatchkine M; Nydegger U; Fearon DT
Nouv Presse Med; 1979 Jun; 8(26):2187-94. PubMed ID: 382108
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of factors of the alternative pathway].
Takemura S; Kondo M
Nihon Rinsho; 1990 Feb; 48 Suppl():630-3. PubMed ID: 2141369
[No Abstract] [Full Text] [Related]
4. Complement aberrations in serum from children with otitis due to S. pneumoniae or H. influenzae.
Prellner K; Nilsson NI
Acta Otolaryngol; 1982; 94(3-4):275-82. PubMed ID: 6983204
[TBL] [Abstract][Full Text] [Related]
5. Complement-regulator factor H and related proteins in otitis media with effusion.
Närkiö-Mäkelä M; Hellwage J; Tahkokallio O; Meri S
Clin Immunol; 2001 Jul; 100(1):118-26. PubMed ID: 11414752
[TBL] [Abstract][Full Text] [Related]
6. Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus.
Whaley K; Schur PH; Ruddy S
Clin Exp Immunol; 1979 Jun; 36(3):408-14. PubMed ID: 114347
[TBL] [Abstract][Full Text] [Related]
7. Alternate and classical pathway components of complement in the normal cornea.
Mondino BJ; Ratajczak HV; Goldberg DB; Schanzlin DJ; Brown SI
Arch Ophthalmol; 1980 Feb; 98(2):346-9. PubMed ID: 6766301
[TBL] [Abstract][Full Text] [Related]
8. Alternative pathway complement activation in rheumatoid arthritis.
El-Ghobarey A; Whaley K
J Rheumatol; 1980; 7(4):453-60. PubMed ID: 6158571
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the properdin amplification loop in membranoproliferative and other forms of glomerulonephritis.
Whaley K; Ward D; Ruddy S
Clin Exp Immunol; 1979 Jan; 35(1):101-6. PubMed ID: 85507
[TBL] [Abstract][Full Text] [Related]
10. [The alternative complement pathway].
Jouvin MH; Kazatchkine M
Pathol Biol (Paris); 1983 Dec; 31(10):839-46. PubMed ID: 6230588
[TBL] [Abstract][Full Text] [Related]
11. Cytolytic complement activity in otitis media with effusion.
Närkiö-Mäkelä M; Meri S
Clin Exp Immunol; 2001 Jun; 124(3):369-76. PubMed ID: 11472396
[TBL] [Abstract][Full Text] [Related]
12. [Paroxysmal nocturnal hemoglobinuria. Increase in proteins of the alternative complement pathway].
de Gramont A; Kazatchkine M; Maillet F; Blanche M; Debray J
Presse Med; 1983 Mar; 12(12):747-50. PubMed ID: 6220312
[TBL] [Abstract][Full Text] [Related]
13. Host defense against opportunist microorganisms following trauma. I. Studies to determine the association between changes in humoral components of host defense and septicemia in burned patients.
Bjornson AB; Altemeier WA; Bjornson HS; Tang T; Iserson ML
Ann Surg; 1978 Jul; 188(1):93-101. PubMed ID: 666383
[TBL] [Abstract][Full Text] [Related]
14. [Alternative complement pathway].
Jouvin MH; Kazatchkine M
Sem Hop; 1984 May; 60(19):1371-8. PubMed ID: 6326330
[TBL] [Abstract][Full Text] [Related]
15. Activation of the alternative complement pathway.
Fearon DT
CRC Crit Rev Immunol; 1979 Nov; 1(1):1-32. PubMed ID: 162484
[No Abstract] [Full Text] [Related]
16. Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes.
Whaley K
J Exp Med; 1980 Mar; 151(3):501-16. PubMed ID: 6444659
[TBL] [Abstract][Full Text] [Related]
17. Control of serum C3 levels by beta 1H and C3b inactivator.
Wyatt RJ; Forristal J; Davis CA; Coleman TH; West CD
J Lab Clin Med; 1980 Jun; 95(6):905-17. PubMed ID: 6445926
[TBL] [Abstract][Full Text] [Related]
18. Purification and quantitation of the components of the alternative complement pathway.
Minta JO; Gee AP
Methods Enzymol; 1983; 93():375-408. PubMed ID: 6223199
[No Abstract] [Full Text] [Related]
19. Complement activity in middle ear effusions.
Bernstein JM; Schenkein HA; Genco RJ; Bartholomew WR
Clin Exp Immunol; 1978 Aug; 33(2):340-6. PubMed ID: 102478
[TBL] [Abstract][Full Text] [Related]
20. Prevention of immune precipitation by purified components of the alternative pathway.
Naama JK; Holme E; Hamilton E; Whaley K
Clin Exp Immunol; 1985 Apr; 60(1):169-77. PubMed ID: 3159522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
